View Full Version : BMY - Bristol-Myers Squibb Co.

01-31-2008, 08:48 AM
Bristol-Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007
Thursday January 31, 7:30 am ET
-- Posts 33% Sales Growth from Continuing Operations in the Fourth Quarter 2007
-- Revises 2008 EPS Guidance Primarily to Reflect the Sale of Medical Imaging
-- Reaffirms Expected Non-GAAP EPS CAGR of at least 15% from 2007 Base Through 2010, Subject to Certain Assumptions
-- Completes Sale of Medical Imaging Business, Reports as Discontinued Operations, with Fourth Quarter EPS of $0.02 and Full-Year EPS of $0.10
-- Posts Fourth Quarter 2007 GAAP Loss Per Share of $0.07 and 2007 Full Year GAAP EPS of $0.99 from Continuing Operations, Impacted by Specified Items
-- Posts Fourth Quarter and Full Year 2007 Non-GAAP EPS of $0.33 and $1.38 from Continuing Operations ($0.35 and $1.48, including Discontinued Operations), Exceeding Top End of Non-GAAP Guidance Range

The chart is at a make or break point. Time to roll?